Article
Medicine, General & Internal
Alessandro Palleschi, Stefania Crotti, Anna Mara Scandroglio, Alfredo Lissoni, Evgeny Fominskiy, Lorenzo Rosso, Davide Tosi, Valeria Musso, Francesco Blasi, Andrea Gori, Mario Nosotti
Summary: This study reports the outcomes of lung transplantation in two patients with COVID-19-associated ARDS and emphasizes the importance of careful recipient selection, including evaluation of single-organ dysfunction, neuro-psychiatric disorders, and MDR colonization.
JOURNAL OF CLINICAL MEDICINE
(2022)
Article
Critical Care Medicine
Christopher S. King, Hannah Mannem, Jasleen Kukreja, Shambhu Aryal, Daniel Tang, Jonathan P. Singer, Ankit Bharat, Juergen Behr, Steven D. Nathan
Summary: The COVID-19 pandemic has caused acute lung injury in millions of individuals worldwide, some of whom may require lung transplantation for severe lung injury or post-COVID fibrosis. Lung transplantation after COVID-19 infection presents unique challenges, including difficulties in evaluation and education, deconditioning, and infectious concerns. Transplant physicians must carefully consider the risks and benefits of lung transplantation in post-COVID fibrosis patients compared to other lung diseases.
Letter
Critical Care Medicine
Jonathan Messika, Matthieu Schmidt, Alexy Tran-Dinh, Pierre Mordant
Summary: The study suggests that some patients with prolonged COVID-19-related ARDS can recover after ECMO support, while others may benefit from lung transplantation. Corticosteroid therapy has been shown to improve lung injury and reduce mortality in prolonged ARDS.
LANCET RESPIRATORY MEDICINE
(2021)
Editorial Material
Critical Care Medicine
Chintan Ramani, Eric M. Davis, John S. Kim, J. Javier Provencio, Kyle B. Enfield, Alex Kadl
Summary: In this study, COVID-19 patients were admitted to the UVA Medical Center ICU and followed up at the UVA Post-COVID-19 ICU clinic. Lung function, exercise capacity, depression, cognitive function, and insomnia were assessed using various tools. The study was approved by the UVA Institutional Review Board.
Article
Medicine, General & Internal
Min-Taek Lee, Moon Seong Baek, Tae Wan Kim, Sun-Young Jung, Won-Young Kim
Summary: This nationwide population-based study aimed to determine whether COVID-19 hospitalization was associated with incident cardiovascular outcomes. The study found that hospitalized patients with COVID-19 were not at an increased risk of cardiovascular outcomes compared to patients with non-COVID-19 pneumonia.
Review
Immunology
Peter R. Kvietys, Hana. M. A. Fakhoury, Sana Kadan, Ahmed Yaqinuddin, Eid Al-Mutairy, Khaled Al-Kattan
Summary: Respiratory tract infection caused by SARS-CoV-2 can lead to acute respiratory distress syndrome (ARDS) and death. Overactive innate immune response is a major factor in ARDS development in COVID-19 patients. The formation of neutrophil extracellular traps (NETs) can trigger immunothrombosis, resulting in blood vessel occlusion and ischemic damage.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY
(2021)
Article
Cell Biology
Giorgio A. Croci, Valentina Vaira, Daria Trabattoni, Mara Biasin, Luca Valenti, Guido Baselli, Massimo Barberis, Elena Guerini Rocco, Giuliana Gregato, Mara Scandroglio, Evgeny Fominskiy, Alessandro Palleschi, Lorenzo Rosso, Mario Nosotti, Mario Clerici, Stefano Ferrero
Summary: This study characterized the immunopathological features of two Italian COVID-19 patients who underwent bilateral lung transplantation, revealing extensive lung damage resembling usual interstitial pneumonia. Gene expression profiling in lung tissues and stimulated blood cells showed overexpression of immune-related genes and a persistent proinflammatory state, indicating sustained immune activation despite immunosuppression.
Article
Immunology
Sarah L. Braunstein, Amanda Wahnich, Rachael Lazar
Summary: A study conducted in New York City found that during 2020, people with HIV had a nearly 30% higher risk of COVID-19 hospitalization and death compared to those without HIV. Among individuals with HIV, certain groups such as women, black, Hispanic/Latino, Native American, and multiracial individuals had elevated rates of adverse COVID-19 outcomes. Factors such as low CD4 count and the presence of non-HIV-related underlying conditions were strongly associated with the risk of COVID-19 hospitalization and death among people with HIV.
JOURNAL OF INFECTIOUS DISEASES
(2023)
Article
Biochemistry & Molecular Biology
Nick Andrews, Julia Stowe, Freja Kirsebom, Samuel Toffa, Ruchira Sachdeva, Charlotte Gower, Mary Ramsay, Jamie Lopez Bernal
Summary: This study examined the relative and absolute effectiveness of mRNA booster vaccination against COVID-19. The results showed that the booster dose of BNT162b2 or mRNA-1273 had a relative effectiveness ranging from 85% to 95% against symptomatic disease, and an absolute effectiveness ranging from 94% to 97%. For hospitalization or death, the absolute effectiveness of the BNT162b2 booster ranged from 97% to 99% in all age groups. The study provides real-world evidence of significantly increased protection from the booster vaccine dose against mild and severe disease.
Article
Public, Environmental & Occupational Health
Christian Bime, Ying Wang, Gordon Carr, Dennis Swearingen, Sherri Kou, Pam Thompson, Vinita Kusupati, Sairam Parthasarathy
Summary: This study aimed to investigate COVID-19-related disparities in clinical presentation and patient outcomes in hospitalized Native American individuals. The study found that Native American individuals were over-represented in COVID-19-related hospitalizations compared with non-Hispanic white individuals. Native American individuals had fewer symptoms at admission, higher prevalence of chronic lung disease in older adults, and a greater risk for ICU admission despite being younger. They also had a higher prevalence of sepsis, were more likely to require invasive mechanical ventilation, had a longer length of stay, and had higher in-hospital mortality compared with non-Hispanic white individuals.
FRONTIERS IN PUBLIC HEALTH
(2023)
Article
Critical Care Medicine
Iain Stewart, Joseph Jacob, Peter M. George, Philip L. Molyneaux, Joanna C. Porter, Richard J. Allen, Shahab Aslani, J. Kenneth Baillie, Shaney L. Barratt, Paul Beirne, Stephen M. Bianchi, John F. Blaikley, James D. Chalmers, Rachel C. Chambers, Nazia Chadhuri, Christopher Coleman, Guilhem Collier, Emma K. Denneny, Annemarie Docherty, Omer Elneima, Rachael A. Evans, Laura Fabbri, Michael A. Gibbons, Fergus Gleeson, Bibek Gooptu, Neil J. Greening, Beatriz Guillen Guio, Ian P. Hall, Neil A. Hanley, Victoria Harris, Ewen M. Harrison, Melissa Heightman, Toby E. Hillman, Alex Horsley, Linzy Houchen-Wolloff, Ian Jarrold, Simon R. Johnson, Mark G. Jones, Fasihul Khan, Rod Lawson, Olivia Leavy, Nazir Lone, Michael Marks, Hamish McAuley, Puja Mehta, Dhruv Parekh, Karen Piper Hanley, Manuela Plate, John Pearl, Krisnah Poinasamy, Jennifer K. Quint, Betty Raman, Matthew Richardson, Pilar Rivera-Ortega, Laura Saunders, Ruth Saunders, Malcolm G. Semple, Marco Sereno, Aarti Shikotra, A. John Simpson, Amisha Singapuri, David J. F. Smith, Mark Spears, Lisa G. Spencer, Stefan Stanel, David R. Thickett, A. A. Roger Thompson, Mathew Thorpe, Simon L. F. Walsh, Samantha Walker, Nicholas David Weatherley, Mark E. Weeks, Jim M. Wild, Dan G. Wootton, Chris E. Brightling, Ling-Pei Ho, Louise Wain, Gisli R. Jenkins
Summary: This study analyzed the data from the UK Interstitial Lung Disease Consortium (UKILD) post-COVID-19 study to estimate the prevalence of residual lung abnormalities in hospitalized COVID-19 patients. The results showed that approximately 11% of recovered COVID-19 patients had residual lung abnormalities, highlighting the need for long-term monitoring.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
(2023)
Article
Biochemistry & Molecular Biology
Martina Vargovic, Neven Papic, Lara Samadan, Mirjana Balen Topic, Adriana Vince
Summary: This study found that serum semaphorin concentrations are associated with the severity and outcomes of COVID-19. SEMA3C, SEMA3F, and SEMA7A levels are increased in COVID-19 patients, while SEMA3A levels are decreased. Serum semaphorin levels have better predictive value than other markers for distinguishing COVID-19 severity.
Article
Medicine, Research & Experimental
Manish Sagar, Katherine Reifler, Michael Rossi, Nancy S. Miller, Pranay Sinha, Laura F. White, Joseph P. Mizgerd
Summary: The study suggests that individuals with prior endemic coronavirus infections were tested more frequently for respiratory infections, but had similar rates of acquiring SARS-CoV-2. Additionally, patients with previous endemic coronavirus infections experienced less severe cases of COVID-19.
JOURNAL OF CLINICAL INVESTIGATION
(2021)
Article
Respiratory System
Nicola Latronico, Elena Peli, Stefano Calza, Federica Rodella, Maria Paola Novelli, Andrea Cella, John Marshall, Dale M. Needham, Frank Antony Rasulo, Simone Piva
Summary: This study reported on the outcomes of 114 COVID-19-associated ARDS survivors evaluated at 3, 6, and 12 months after discharge from the ICU, showing persisting impairment in physical function, while activities of daily living, cognitive and mental health status, and health-related quality of life may be less impaired. The study found improvements in handgrip dynamometry and cognitive impairment over time, but 6 min walk test, severe fatigue, depression, anxiety, and post-traumatic stress disorder symptoms did not show significant improvements.
Article
Oncology
Joseph Balnis, Andy Madrid, Kirk J. Hogan, Lisa A. Drake, Hau C. Chieng, Anupama Tiwari, Catherine E. Vincent, Amit Chopra, Peter A. Vincent, Michael D. Robek, Harold A. Singer, Reid S. Alisch, Ariel Jaitovich
Summary: The study compared DNA CpG methylation in blood samples from COVID-19 patients and healthy controls collected before the pandemic, revealing differentially methylated regions associated with acute illness and autoimmune disorders. The results also showed a correlation between hyper-methylation in COVID-19 patients and worse outcomes, suggesting that DNA methylation may influence the expression of genes that regulate COVID-19 progression.
CLINICAL EPIGENETICS
(2021)
Article
Biochemistry & Molecular Biology
Ankit Hanmandlu, Lisha Zhu, Tinne C. J. Mertens, Scott Collum, Weizhen Bi, Feng Xiong, Ruoyu Wang, Rajarajan T. Amirthalingam, Dewei Ren, Leng Han, Soma S. S. K. Jyothula, Wenbo Li, W. Jim Zheng, Harry Karmouty-Quintana
Summary: Idiopathic pulmonary fibrosis (IPF) is a chronic lung disease associated with fibroblast expansion and excessive extracellular matrix deposition. This study identified genetic differences between IPF fibroblasts and healthy fibroblasts, and discovered important genes and pathways related to IPF. Modulation of chromatin accessibility may play a significant role in the pathogenesis of lung fibrosis.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
(2022)
Article
Medicine, Research & Experimental
Cory Wilson, Tinne C. J. Mertens, Pooja Shivshankar, Weizen Bi, Scott D. Collum, Nancy Wareing, Junsuk Ko, Tingting Weng, Ram P. Naikawadi, Paul J. Wolters, Pascal Maire, Soma S. K. Jyothula, Rajarajan A. Thandavarayan, Dewei Ren, Nathan D. Elrod, Eric J. Wagner, Howard J. Huang, Burton F. Dickey, Heide L. Ford, Harry Karmouty-Quintana
Summary: The transcription factor SIX1 is found to play a crucial role in pulmonary fibrosis, and its overexpression may contribute to the development of fibrosis. SIX1 binds to the MIF promoter, regulating the expression of MIF and participating in the pathogenesis of lung fibrosis.
Article
Biochemistry & Molecular Biology
Victor Tseng, Scott Collum, Ayed Allawzi, Kathryn Crotty, Samantha Yeligar, Aaron Trammell, M. Ryan Smith, Bum-Yong Kang, Roy L. Sutliff, Jennifer L. Ingram, Soma S. S. K. Jyothula, Rajarajan A. Thandavarayan, Howard J. Huang, Eva S. Nozik, Eric J. Wagner, C. Michael Hart, Harry Karmouty-Quintana
Summary: This study identifies a novel mechanism of hyaluronan (HA) hyper-synthesis and reveals its effects on pulmonary vascular cell metabolism and remodeling. Modulating the expression of HA synthase-2 (HAS2) can improve experimental models of pulmonary hypertension (PH).
Meeting Abstract
Critical Care Medicine
Sandeep Patri, Bindu Akkanti, Soma S. Jyothula, Manish K. Patel
Article
Medicine, General & Internal
Soma S. K. Jyothula, Andrew Peters, Yafen Liang, Weizhen Bi, Pooja Shivshankar, Simon Yau, Puneet S. Garcha, Xiaoyi Yuan, Bindu Akkanti, Scott Collum, Nancy Wareing, Rajarajan A. Thandavarayan, Fernando Poli de Frias, Ivan O. Rosas, Bihong Zhao, L. Maximilian Buja, Holger K. Eltzschig, Howard J. Huang, Harry Karmouty-Quintanaa
Summary: This study analyzed fibrotic markers in the lungs of non-resolvable COVID-19 patients and identified a unique fibrotic gene signature dominated by the overexpression of pro-fibrotic genes, including collagens and periostin. The study also revealed an increased expression of Collagen Triple Helix Repeat Containing 1 (CTHRC1) in areas rich in alpha smooth muscle expression, indicating the presence of myofibroblasts. Additionally, there was a significant increase in cytokeratin (KRT) 5 and 8 expressing cells adjacent to fibroblastic areas and in areas of apparent epithelial bronchiolization.
Letter
Immunology
Luis Ostrosky-Zeichner
CLINICAL INFECTIOUS DISEASES
(2023)
Article
Immunology
Kenji Okumura, Soma Jyothula, Thomas Kaleekal, Abhay Dhand
Summary: The characteristics and outcomes of lung transplant recipients with COVID-19-associated end-stage lung disease were analyzed. The study found that COVID-19 patients had longer hospital stays after transplant, but one-year patient survival was similar to non-COVID-19 recipients. However, COVID-19 remained one of the most common causes of death during the immediate post-transplant period.
CLINICAL INFECTIOUS DISEASES
(2023)
Letter
Immunology
Soma S. S. K. Jyothula, Jayeshkumar Patel, Abhay Dhand
TRANSPLANT INFECTIOUS DISEASE
(2023)
Article
Immunology
Dallas J. Smith, Jeremy A. W. Gold, Tom Chiller, Nirma D. Bustamante, Maria Julia Marinissen, Gabriel Garcia Rodriquez, Vladimir Brian Gonzalez Cortes, Celida Duque Molina, Samantha Williams, Axel A. Vazquez Deida, Katrina Byrd, Peter G. Pappas, Thomas F. Patterson, Nathan P. Wiederhold, George R. Thompson III, Luis Ostrosky-Zeichner, Fungal Meningitis Response Team
Summary: Public health officials are responding to a multistate and multinational fungal meningitis outbreak that occurred in Matamoros, Mexico from January 1 to May 13, 2023. A total of 185 residents in 22 US states and jurisdictions have been identified as potentially at risk, with 10 confirmed cases and 8 deaths reported. The causative agent has been identified as the Fusarium solani species complex, and most available antifungals have shown poor activity against it. Current treatment recommendations include triple therapy with voriconazole, liposomal amphotericin B, and fosmanogepix.
CLINICAL INFECTIOUS DISEASES
(2023)
Article
Cardiac & Cardiovascular Systems
Nauman A. Khan, Bharat S. Bhandari, Soma Jyothula, Daniel Ocazionez, Jamie Buryanek, Pushan P. Jani
Summary: This article describes four distinct manifestations of amyloidosis involving the lung and reviews their clinical, radiological, and pathological features, as well as the evidence for treatment in each presentation.
RESPIRATORY MEDICINE
(2023)
Article
Immunology
M. Hong Nguyen, Luis Ostrosky-Zeichner, Peter G. Pappas, Thomas J. Walsh, Joseph Bubalo, Barbara D. Alexander, Marisa H. Miceli, Jeanette Jiang, Yi Song, George R. Thompson
Summary: This study assessed the real-world use of mold-active triazoles (MATs) for the prevention of invasive fungal diseases (IFDs) and found that MATs were effective in preventing IFDs and had a low discontinuation rate due to adverse drug reactions (ADRs).
OPEN FORUM INFECTIOUS DISEASES
(2023)
Article
Immunology
Mohanad M. Al-Obaidi, Luis Ostrosky-Zeichner, David E. Nix
Summary: This study analyzed the trends in outpatient azole antifungals use and costs from 2013 to 2020. The results showed an increase in the use of azole antifungals among Medicare Part D enrollees, particularly in the southern US regions. The overall costs of outpatient azole antifungals consistently increased over the study period. These findings provide insights into the impact of azole antifungal prescriptions and the potential for increased antifungal resistance.
OPEN FORUM INFECTIOUS DISEASES
(2023)
Article
Respiratory System
Khushboo Goel, Nicholas Egersdorf, Amar Gill, Danting Cao, Scott D. Collum, Soma S. Jyothula, Howard J. Huang, Maor Sauler, Patty J. Lee, Susan Majka, Harry Karmouty-Quintana, Irina Petrache
Summary: This study investigated the remodeling of pulmonary blood vessels in COPD-PH patients and found that remodeling of small and microvascular pulmonary blood vessels is associated with the development of COPD and COPD-PH. Decreased expression of miR126 and reciprocal increase in ADAM9 may regulate endothelial cell survival and vascular remodeling in COPD and COPD-PH.
RESPIRATORY RESEARCH
(2022)